Ad
related to: bristol-myers squibb
Search results
Bristol Myers Squibb’s Breyanzi gains FDA approval for lymphoma
Pharmaceutical Technology via Yahoo Finance· 5 hours agoBristol Myers Squibb (BMS) has received approval from the US Food and Drug Administration for...
Bristol Myers Squibb Company (BMY) Is a Trending Stock: Facts to Know Before Betting on It
Zacks via Yahoo Finance· 1 day agoBristol Myers (BMY) has received quite a bit of attention from Zacks.com users lately. Therefore, it...
Bristol-Myers Squibb (NYSE:BMY) Shares Down 1.1%
ETF DAILY NEWS· 6 days agoShares of Bristol-Myers Squibb (NYSE:BMY – Get Free Report) fell 1.1% during trading on Thursday . The company traded as low as $41.58 and last traded at $41.89. 3,501,801 shares changed hands ...
Bristol-Myers Squibb's Options: A Look at What the Big Money is Thinking - Bristol-Myers Squibb...
Benzinga· 21 hours agoLoading... Loading... Deep-pocketed investors have adopted a bearish approach towards Bristol-Myers Squibb BMY , and it's something market players shouldn't ignore. Our tracking of public options ...
Q2 2025 Earnings Estimate for Bristol-Myers Squibb Issued By Zacks Research (NYSE:BMY)
ETF DAILY NEWS· 3 days agoBristol-Myers Squibb (NYSE:BMY – Free Report) – Investment analysts at Zacks Research raised their Q2 2025 earnings estimates for shares of Bristol-Myers Squibb in a research report issued on ...
US FDA expands use of Bristol's cell therapy to treat rare blood cancer
Reuters via Yahoo News· 22 hours ago(Reuters) -Bristol Myers Squibb said on Thursday the U.S. FDA had allowed expanded use of its cell...
Bristol-Myers Squibb Co. [BMY] Investment Appeal on the Rise – Knox Daily
Knox Daily· 2 days agoBristol-Myers Squibb Co.’s filing revealed that its Chief Executive Officer BOERNER CHRISTOPHER S. acquired Company’s shares for reported $99560.0 on Dec 05 ’23. In the deal valued at $49.78 ...
Bristol Myers Squibb checks 'yes' on another Prothena neurodegenerative therapy
FierceBiotech· 2 days agoBristol Myers Squibb is again dipping into the well of therapies being developed by Prothena, this...
Pharmaceutical Giant Cencora Confirms Patient Data Breach Impacting over a Dozen Pharma Companies -...
CPO Magazine· 3 hours agoU.S. pharmaceutical giant Cencora has disclosed that the February 2024 data breach leaked sensitive...
Bristol Myers Squibb Shares Cross 6% Yield Mark
Forbes· 2 days agoIn trading on Wednesday, shares of Bristol Myers Squibb were yielding above the 6% mark based on its quarterly dividend (annualized to $2.4), with the stock changing hands as low as $39.94 on ...